A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Clinical trial NCT01506947 · COMPLETED

Trial details

NCT number: NCT01506947
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Secondary Hyperparathyroidism Stage 5 Chronic Kidney Diseases

Start date: 2012-05-10
Primary completion: 2016-04-07
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.